Choose a country to view content specific to your location
Enterovirus infections are caused by many different viruses including coxsackievirus, echovirus, enterovirus, and poliovirus. They are responsible for causing illnesses in 10 to 30 million people each year in the United States, primarily in the summer and fall and they are most common among children. Infections are highly contagious and typically affect many people in a community, sometimes reaching epidemic proportions.
Contact us to learn more about Meridian’s molecular or immunoassay reagent portfolio. We want to hear from you!
| Name | Type | Format | Host/Source | Isotype | Tested Apps | Unit | Catalog | Buffer | Immunogen | Recombinant | Description | Notes | Safety Data Sheet | COA/Test Release | Product Information Sheet | New Product | Recommended Product | Order a Sample | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Enterovirus D EV70 Recomb | Antigen | Purified | E. coli | N/A | LF,IM | MG | R01765 | Yes | — — | COA/Test Release | — | 0 | 0 | |||||||
| Enterovirus A EV71 Recomb | Antigen | Purified | E. coli | N/A | LF,IM | MG | R01764 | Yes | — — | COA/Test Release | — | 0 | 0 | |||||||
| Enterovirus A Cox A16 Recomb | Antigen | Purified | E. coli | N/A | LF,IM | MG | R01763 | Yes | — — | COA/Test Release | — | 0 | 0 | |||||||
| Salmonella Typhi Flag. Recomb | Antigen | Purified | E. coli | N/A | EIA | MG | R01746 | Yes | — — | COA/Test Release | — | 0 | 0 | |||||||
| Enterovirus B Cox B3 Recomb | Antigen | Purified | E. coli | N/A | LF,IM,ST | MG | R01737 | Yes | — — | COA/Test Release | — | 0 | 0 | |||||||
| Enterovirus C. Cox A24 Recomb | Antigen | Purified | E. coli | N/A | LAT,IM,ST | MG | R01736 | Yes | — — | COA/Test Release | — | 0 | 0 | |||||||
| Enterovirus B Echo 18 Recomb | Antigen | Purified | E. coli | N/A | LF,IM,ST | MG | R01735 | Yes | — — | COA/Test Release | — | 0 | 0 | |||||||
| Salmonella Typhi H Ag, Recomb. | Antigen | Purified | E. coli | N/A | LF | MG | R01699 | Yes | Safety Data Sheet — | COA/Test Release | — | 0 | 0 | |||||||
| Salmonella typhi OMP, Recomb. | Antigen | Purified | E. coli | N/A | EIA,WB | MG | R01670 | Yes | Safety Data Sheet — | COA/Test Release | — | 0 | 0 | |||||||
| Salmonella Typhi Pagc Recomb. | Antigen | Purified | E. coli | N/A | N/A | MG | R01569 | Yes | Safety Data Sheet — | COA/Test Release | — | 0 | 0 | |||||||
| MAb to Salmonella Typhimurium | Monoclonal | Purified | Mouse | IgG1 | EIA | MG | C86309M | No | Safety Data Sheet — | COA/Test Release | — | 0 | 0 | |||||||
| MAb to Salmonella (abd Groups) | Monoclonal | Purified | Mouse | IgG1 | DB,EIA,IFA | MG | C86109M | No | Safety Data Sheet — | COA/Test Release | — | 0 | 0 | |||||||
| MAb to Salmonella Species | Monoclonal | Purified | Mouse | IgG2b | EIA,IFA | MG | C65958M | No | — — | COA/Test Release | — | 0 | 0 | |||||||
| MAb to Salmonella Species | Monoclonal | Purified | Mouse | IgG2b | EIA,IFA,ST | MG | C65957M | No | Safety Data Sheet — | COA/Test Release | — | 0 | 0 | |||||||
| MAb to Salmonella (ABCDE Grps) | Monoclonal | Purified | Mouse | IgG1 | EIA,IFA,DB | MG | C65635M | No | — — | COA/Test Release | — | 0 | 0 | |||||||
| MAb to Salmonella Paratyphi A | Monoclonal | Purified | Mouse | IgG3 | EIA,IFA,ST | MG | C01884M | No | Safety Data Sheet — | COA/Test Release | — | 0 | 0 | |||||||
| MAb to Enterovirus | Monoclonal | Purified | Mouse | IgG2a | EIA,IFA | MG | C01700M | No | Safety Data Sheet — | COA/Test Release | — | 0 | 0 | |||||||
| MAb to Enterovirus 70 | Monoclonal | Purified | Mouse | IgG3 | EIA,IFA | MG | C01670M | No | Safety Data Sheet — | COA/Test Release | — | 0 | 0 | |||||||
| MAb to Salmonella Typhi | Monoclonal | Purified | Mouse | IgG2a | EIA,IFA,ST,Pr,LF | MG | C01362M | No | Safety Data Sheet — | COA/Test Release | — | 0 | 0 | |||||||
| MAb to Salmonella Species | Monoclonal | Purified | Mouse | IgG2b | EIA,IFA,Pr | MG | C01361M | No | Safety Data Sheet — | COA/Test Release | — | 0 | 0 | |||||||
| MAb to Salmonella Species | Monoclonal | Purified | Mouse | IgG3 | EIA,IFA,Pr,ST | MG | C01360M | No | — — | COA/Test Release | — | 0 | 0 | |||||||
| MAb to Salmonella Species | Monoclonal | Purified | Mouse | IgG2a | EIA,IFA,Pr | MG | C01359M | No | — — | COA/Test Release | — | 0 | 0 | |||||||
| MAb to Salmonella Species | Monoclonal | Purified | Mouse | IgG2a | EIA,Pr,IFA | MG | C01358M | No | — — | COA/Test Release | — | 0 | 0 | |||||||
| Rabbit anti Salmonella Sp. | Polyclonal | Biotin | Rabbit | N/A | EIA,IFA | ML | B65707R | No | — — | COA/Test Release | — | 0 | 0 | |||||||
| Rabbit anti Salmonella Sp. | Polyclonal | HRP | Rabbit | N/A | EIA,IHC | ML | B65704R | No | — — | COA/Test Release | — | 0 | 0 | |||||||
| Rabbit anti Salmonella Sp. | Polyclonal | FITC | Rabbit | N/A | IFA | ML | B65703R | No | — — | COA/Test Release | — | 0 | 0 | |||||||
| Rabbit anti Salmonella Sp. | Polyclonal | Purified | Rabbit | N/A | EIA,IFA | ML | B65701R | No | Safety Data Sheet — | COA/Test Release | — | 0 | 0 | |||||||
| Salmonella Typhimurium | Antigen | Lysate | Cell Culture | N/A | LF,CON,ST | ML | A01716N | No | Safety Data Sheet — | COA/Test Release | — | 0 | 0 | |||||||
| Salmonella typhi | Antigen | Lysate | Cell Culture | N/A | LF,CON | ML | A01699N | No | Safety Data Sheet — | COA/Test Release | — | 0 | 0 | |||||||
| Salmonella Enteritidis | Antigen | Lysate | Cell Culture | N/A | LF,CON | ML | A01702N | No | Safety Data Sheet — | COA/Test Release | — | 0 | 0 | |||||||
| Salmonella Paratyphi B | Antigen | Lysate | Cell Culture | N/A | LF,CON | ML | A01701N | No | Safety Data Sheet — | COA/Test Release | — | 0 | 0 | |||||||
| Salmonella Paratyphi A | Antigen | Lysate | Cell Culture | N/A | LF,CON | ML | A01700N | No | Safety Data Sheet — | COA/Test Release | — | 0 | 0 |
| Capture Antibody | Detection Antibody |
|---|---|
| C01359M | C01361M |
| C01358M | C01361M |
Not seeing what you’re looking for? Inquire about a new product
Enteroviruses infect an estimated 50 million people each year in the US and possibly a billion or more worldwide. Approximately 75% of enterovirus infections occur in children under 15 years of age, and the occurrence rates are highest in children under 1 year of age. Transmission occurs orally, either via aerosol or ingestion of contaminated food. Approximately 50-80% of enterovirus infections are mild or asymptomatic; however, they can also develop into severe and life-threatening diseases. Serologic studies have distinguished over 70 human enterovirus serotypes associated with 26 different syndromes and diseases, including coronary heart disease, type 1 diabetes, hand-foot-and-mouth disease, polio, and meningitis. Traditionally, enteroviruses were classified into four separate species: coxsackie, echovirus, enterovirus, and poliovirus. However, due to large overlaps in their epidemiologic and clinical characteristics, their taxonomy has changed, and newly identified viruses are now numbered, starting with EV68. To date, the following enterovirus subtypes have been identified:
Subtype Diseases
Poliovirus 1-3 Paralysis, aseptic meningitis, encephalitis, poliomyelitis
Coxsackie A1-A24 Herpangina, hand-foot-mouth, common cold
Coxsackie B1-B6 Pleurodynia, aseptic meningitis, encephalitis, pericarditis, myocarditis
Echovirus 1-9, 11-31 Paralysis, aseptic meningitis, encephalitis
Numbered Enteroviruses Herpangina, hand-foot-and-mouth, conjunctivitis (EV70), aseptic meningitis (eg. EV71)
Enterovirus outbreaks are common in the summer and fall, though they can cause infections year-round in tropical parts of the world. Several serotypes have been responsible for large outbreaks including:
Diagnostic methods for enterovirus include virus isolation, nucleic acid testing (NAT), and serological tests such as ELISA, complement fixation (CF), and neutralization assays. In particular, IgM ELISAS have proven very useful in cases of meningitis when cerebral spinal fluid samples are not available. Also, the rapid serotype identification of enterovirus is important in differentiating non-poliovirus enterovirus pathogens from vaccine strain polioviruses that can be shed for some time after vaccination, especially in age groups in which oral poliovirus vaccines are usually administered.
Have questions about a product? Want to learn more about Meridian’s molecular or immunoassay reagent portfolio? We want to hear from you!
By submitting your information in this form, you agree that your personal information may be stored and processed in any country where we have facilities or service providers, and by using our “Contact Us” page you agree to the transfer of information to countries outside of your country of residence, including to the United States, which may provide for different data protection rules than in your country. The information you submit will be governed by our Privacy Statement.
| Type |
|---|
| Format |
| Host/Source |
| Isotype |
| Tested Apps |
| Unit |
| Catalog |
| Buffer |
| Immunogen |
| COFA Description |
| COFA Notes |
| Recombination |
| SDS |
| COA |
| Product Information Sheet |
| Request Sample |